| 发明名称 |
PHARMACEUTICAL COMBINATION AND USES THEREOF |
| 摘要 |
The invention relates to pharmaceutical combinations comprising a vascular disrupting agent, in particular the tubulin polymerisation inhibitor BNC105, and an immunotherapeutic agent, in particular an anti-PD-L1, PD-1 or CTLA-4 antibody, and use thereof in the treatment of cancer. |
| 申请公布号 |
WO2016197204(A1) |
申请公布日期 |
2016.12.15 |
| 申请号 |
WO2016AU50478 |
申请日期 |
2016.06.10 |
| 申请人 |
BIONOMICS LIMITED |
发明人 |
KREMMIDIOTIS, Gabriel;LAVRANOS, Tina;INGLIS, Daniel |
| 分类号 |
A61K31/343;A61K31/33;A61K31/381;A61K31/404;A61K39/395;A61P35/00 |
主分类号 |
A61K31/343 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
